Endorectal Advancement Flaps for Perianal Fistulae in Crohn’s Disease: Careful Patient Selection Leads to Optimal Outcomes

[1]  T. Matsui,et al.  Clinical and Pharmacokinetic Factors Associated With Adalimumab‐Induced Mucosal Healing in Patients With Crohn’s Disease , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  S. Takano,et al.  Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease , 2017, Intestinal research.

[3]  M. Regueiro,et al.  Guidelines for the multidisciplinary management of Crohn's perianal fistulas: summary statement. , 2015, Inflammatory bowel diseases.

[4]  I. Molendijk,et al.  Disappointing Durable Remission Rates in Complex Crohn's Disease Fistula , 2014, Inflammatory bowel diseases.

[5]  C. Viganò,et al.  Perianal disease is associated with psychiatric co-morbidity in Crohn’s disease in remission , 2014, International Journal of Colorectal Disease.

[6]  L. Siproudhis,et al.  Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  W. Bemelman,et al.  The anal fistula plug treatment compared to the mucosal advancement flap for cryptoglandular high transsphincteric perianal fistulas: A double blinded multicenter randomized trial , 2010 .

[8]  P. Rutgeerts,et al.  Infliximab, azathioprine, or combination therapy for Crohn's disease. , 2010, The New England journal of medicine.

[9]  A. Kaiser,et al.  Endorectal Advancement Flap for Cryptoglandular or Crohn's Fistula-in-Ano , 2010, Diseases of the colon and rectum.

[10]  Jaime E. Sánchez,et al.  Fecal Diversion in Perirectal Fistulizing Crohn's Disease is an Underutilized and Potentially Temporary Means of Successful Treatment , 2009, The American surgeon.

[11]  A. Mellgren,et al.  Does Infliximab Infusion Impact Results of Operative Treatment for Crohn’s Perianal Fistulas? , 2007, Diseases of the colon and rectum.

[12]  N. Uribe,et al.  Clinical and manometric results of endorectal advancement flaps for complex anal fistula , 2007, International Journal of Colorectal Disease.

[13]  M. Bala,et al.  Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. , 2005, Gastroenterology.

[14]  P. Rutgeerts,et al.  Infliximab maintenance therapy for fistulizing Crohn's disease. , 2004, The New England journal of medicine.

[15]  M. Kamm,et al.  The clinical course of fistulating Crohn's disease , 2003, Alimentary pharmacology & therapeutics.

[16]  M. Regueiro,et al.  Treatment of Perianal Fistulizing Crohn's Disease with Infliximab Alone or as an Adjunct to Exam Under Anesthesia with Seton Placement , 2003, Inflammatory bowel diseases.

[17]  P. Rutgeerts,et al.  Infliximab for the treatment of fistulas in patients with Crohn's disease. , 1999, The New England journal of medicine.

[18]  V. Fazio,et al.  Advancement sleeve flaps for treatment of severe perianal Crohn's disease , 1998, The British journal of surgery.

[19]  E. Weiss,et al.  Endorectal advancement flap in perianal Crohn's disease. , 1998, The American surgeon.

[20]  F. Makowiec,et al.  Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn's disease , 1995, The British journal of surgery.

[21]  D. Bartolo,et al.  Treatment of trans‐sphincteric fistulae by full thickness anorectal advancement flaps , 1990, The British journal of surgery.

[22]  I. Kodner,et al.  Endorectal sliding flap repair of complicated anterior anoperineal fistulas , 1988, Diseases of the colon and rectum.

[23]  J. Coller,et al.  Anal complications in Crohn's disease , 1981, Diseases of the colon and rectum.